Skip to main content

Table 4 Cox proportional hazards model for overall survival

From: Effect of prior antibiotic or chemotherapy treatment on immunotherapy response in non-small cell lung cancer

 

Alive (n = 84)

Deceased (n = 172)

Univariate

Multivariate1

 

N (%)

N (%)

Hazard Ratio

(95% CI)

Hazard Ratio (95% CI)

P-value

Antibiotic Use

 ABT-

70 (83.3)

140 (81.4)

1.00

1.00

 

 ABT + 

14 (16.7)

32 (18.6)

1.33 (0.91–1.96)

1.35 (0.91–2.02)

0.140

PPI Use

 No

62 (73.8)

133 (77.3)

1.00

1.00

 

 Yes

22 (26.2)

39 (22.7)

0.91 (0.63–1.29)

0.92 (0.64–1.33)

0.667

Prior Chemotherapy

 No

44 (52.4)

66 (38.4)

1.00

1.00

 

 Yes

40 (47.6)

106 (61.6)

1.42 (1.04–1.93)

1.47 (1.07–2.03)

0.018*

Age (mean [sd])

 NA

65.6 [10.1]

65.4 [9.2]

1.00 (0.99–1.02)

1.00 (0.98–1.02)

0.933

ECOG Performance Status

 0

24 (28.6)

33 (19.3)

1.00

1.00

 

 1/2

60 (71.4)

138 (80.7)

1.75 (1.19–2.57)

1.75 (1.19–2.57)

0.005*

Targeted Therapy

 No

73 (86.9)

142 (82.6)

1.00

1.00

 

 Yes

11 (13.1)

30 (17.4)

1.02 (0.69–1.52)

1.00 (0.66–1.52)

0.995

Smoking Status

 Never

13 (15.5)

25 (14.5)

1.00

1.00

 

 Former

57 (67.9)

127 (73.8)

1.30 (0.85–2.00)

1.36 (0.88–2.10)

0.168

 Current

14 (16.7)

20 (11.6)

1.02 (0.57–1.84)

1.06 (0.58–1.92)

0.859

  1. *Statistically Significant, when p < 0.05; 1: Adjusted for PPI, Chemotherapy, Age (Continuous), ECOG (0 vs. combined 1/2), Targeted Therapy, and Smoking Status; *Dead considered as event/1. Alive is reference/0. PPI: Proton pump inhibitor